Guardant Health [GH] vs Thermo Fisher [TMO] Detailed Stock Comparison

Guardant Health

NASDAQ
Loading...

Thermo Fisher

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Guardant Health wins in 8 metrics, Thermo Fisher wins in 10 metrics, with 0 ties. Thermo Fisher appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricGuardant HealthThermo FisherBetter
P/E Ratio (TTM)-17.4526.89Guardant Health
Price-to-Book Ratio-25.243.63Guardant Health
Debt-to-Equity Ratio-4.3769.62Guardant Health
PEG Ratio3.664.73Guardant Health
EV/EBITDA-20.3819.60Guardant Health
Profit Margin (TTM)-49.93%15.24%Thermo Fisher
Operating Margin (TTM)-45.75%17.84%Thermo Fisher
EBITDA Margin (TTM)N/A17.84%N/A
Return on Equity312.48%13.42%Guardant Health
Return on Assets (TTM)-19.57%4.97%Thermo Fisher
Free Cash Flow (TTM)$-274.94M$7.27BThermo Fisher
Dividend YieldN/A0.31%N/A
1-Year Return177.35%-12.30%Guardant Health
Price-to-Sales Ratio (TTM)9.334.24Thermo Fisher
Enterprise Value$8.54B$212.08BThermo Fisher
EV/Revenue Ratio10.314.91Thermo Fisher
Gross Profit Margin (TTM)65.01%40.61%Guardant Health
Revenue per Share (TTM)$7$114Thermo Fisher
Earnings per Share (Diluted)$-3.46$18.04Thermo Fisher
Beta (Stock Volatility)1.460.76Thermo Fisher
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Guardant Health vs Thermo Fisher Stock Performance Analysis

Loading Price Chart...

Guardant Health
Thermo Fisher
Guardant Health Stock Overview | Thermo Fisher Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Guardant Health-1.90%2.13%-7.59%22.48%41.32%93.45%
Thermo Fisher-1.09%14.32%7.68%22.72%7.34%0.46%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Guardant Health177.35%10.24%-43.19%110.48%110.48%110.48%
Thermo Fisher-12.30%0.26%12.97%314.92%1,006.11%1,622.87%

News Based Sentiment: Guardant Health vs Thermo Fisher

Guardant Health

News based Sentiment: POSITIVE

Guardant Health delivered a strong Q2 performance with revenue exceeding expectations and raised full-year guidance. A significant legal victory and key partnerships further bolster the company's position, though continued cash burn remains a concern. These developments suggest a positive trajectory for the company, making October a significant month for investors.

View Guardant Health News Sentiment Analysis

Thermo Fisher

News based Sentiment: POSITIVE

October 2025 was a demonstrably positive month for Thermo Fisher Scientific, characterized by a significant stock surge, strategic financial maneuvers, and proactive investments in innovation and customer support. These developments collectively reinforce a strong growth trajectory and positive investor sentiment.

View Thermo Fisher News Sentiment Analysis

Performance & Financial Health Analysis: Guardant Health vs Thermo Fisher

MetricGHTMO
Market Information
Market Cap i$7.73B$201.36B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i2,782,0302,827,260
90 Day Avg. Volume i2,486,5871,990,550
Last Close$61.46$524.96
52 Week Range$20.14 - $68.00$385.46 - $616.57
% from 52W High-9.62%-14.86%
All-Time High$181.07 (Feb 08, 2021)$672.34 (Dec 27, 2021)
% from All-Time High-66.06%-21.92%
Growth Metrics
Quarterly Revenue Growth0.31%0.03%
Quarterly Earnings Growth0.31%0.05%
Financial Health
Profit Margin (TTM) i-0.50%0.15%
Operating Margin (TTM) i-0.46%0.18%
Return on Equity (TTM) i3.12%0.13%
Debt to Equity (MRQ) i-4.3769.62
Cash & Liquidity
Book Value per Share (MRQ)$-2.45$133.77
Cash per Share (MRQ)$4.19$16.92
Operating Cash Flow (TTM) i$-238,546,000$7.58B
Levered Free Cash Flow (TTM) i$-131,174,000$5.18B
Dividends
Last 12-Month Dividend Yield iN/A0.31%
Last 12-Month Dividend iN/A$1.21

Valuation & Enterprise Metrics Analysis: Guardant Health vs Thermo Fisher

MetricGHTMO
Price Ratios
P/E Ratio (TTM) i-17.4526.89
Forward P/E i-22.8720.65
PEG Ratio i3.664.73
Price to Sales (TTM) i9.334.24
Price to Book (MRQ) i-25.243.63
Market Capitalization
Market Capitalization i$7.73B$201.36B
Enterprise Value i$8.54B$212.08B
Enterprise Value Metrics
Enterprise to Revenue i10.314.91
Enterprise to EBITDA i-20.3819.60
Risk & Other Metrics
Beta i1.460.76
Book Value per Share (MRQ) i$-2.45$133.77

Financial Statements Comparison: Guardant Health vs Thermo Fisher

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)GHTMO
Revenue/Sales i$203.47M$10.36B
Cost of Goods Sold i$74.72M$6.13B
Gross Profit i$128.75M$4.24B
Research & Development i$88.52M$342.00M
Operating Income (EBIT) i$-111.04M$1.82B
EBITDA i$-83.84M$2.73B
Pre-Tax Income i$-94.87M$1.62B
Income Tax i$290,000$95.00M
Net Income (Profit) i$-95.16M$1.51B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)GHTMO
Cash & Equivalents i$698.57M$4.13B
Total Current Assets i$927.03M$23.38B
Total Current Liabilities i$225.75M$13.17B
Long-Term Debt i$1.28B$31.37B
Total Shareholders Equity i$-250.79M$49.49B
Retained Earnings i$-2.67B$54.45B
Property, Plant & Equipment i$140.50MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)GHTMO
Operating Cash Flow i$-49.41M$2.15B
Capital Expenditures i$-4.46M$-350.00M
Free Cash Flow i$-67.15M$361.00M
Debt Repayment iN/A$-838.00M
Common Stock Repurchase i$-45.01M$-2.00B

Short Interest & Institutional Ownership Analysis

MetricGHTMO
Shares Short i8.74M3.83M
Short Ratio i3.672.34
Short % of Float i0.07%0.01%
Average Daily Volume (10 Day) i2,782,0302,827,260
Average Daily Volume (90 Day) i2,486,5871,990,550
Shares Outstanding i123.99M380.77M
Float Shares i119.85M376.74M
% Held by Insiders i0.04%0.00%
% Held by Institutions i0.99%0.92%

Dividend Analysis & Yield Comparison: Guardant Health vs Thermo Fisher

MetricGHTMO
Last 12-Month Dividend iN/A$1.21
Last 12-Month Dividend Yield iN/A0.31%
3-Year Avg Annual Dividend iN/A$1.33
3-Year Avg Dividend Yield iN/A0.07%
3-Year Total Dividends iN/A$3.99
Ex-Dividend DateN/AMar 14, 2025